Oncternal Therapeutics ONCT

$ 1.13 1.93%

Quarterly report 2024-Q3
added 11-06-2024

Oncternal Therapeutics EV/EBITDA Ratio 2011-2024 | ONCT

Annual EV/EBITDA Ratio Oncternal Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.32	0.446	-1.24	0.186	-8.46	-2.67	-3.67	-1.06	-2.29	-5.32	-8.38

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.32	-8.46	-2.83